• Revenue milestone target: Poly Medicure is maintaining its revenue target to hit the ₹2,300 to ₹2,400 crore milestone, supported by the full-year revenue contribution of two international acquisitions made late last year.
• Export growth outlook: The company expects a 15% increase in ex-India exports for the current year based on existing operating conditions.
• Acquired business growth: Revenue for CTFE is projected to grow between 12% and 13%, while Pendracare is expected to deliver around 15% revenue growth over last year.
• European market recovery: The European business has normalized and returned to growth in the fourth quarter, supporting strong ongoing guidance for upcoming quarters.